NCT03893929View on ClinicalTrials.gov

The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population

RecruitingOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

October 7, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST

New Biological markers for prostate cancer diagnosis and management

To identify potential new blood and urine markers for the diagnosis, risk stratification and prognosis prediction for prostate cancer in Chinese population.

Trial Locations (1)

Unknown

RECRUITING

Prince of Wales Hospital, Shatin

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER